| pubmed-article:2773792 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:2773792 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:2773792 | lifeskim:mentions | umls-concept:C0035647 | lld:lifeskim |
| pubmed-article:2773792 | lifeskim:mentions | umls-concept:C0038435 | lld:lifeskim |
| pubmed-article:2773792 | lifeskim:mentions | umls-concept:C0025663 | lld:lifeskim |
| pubmed-article:2773792 | lifeskim:mentions | umls-concept:C0043202 | lld:lifeskim |
| pubmed-article:2773792 | lifeskim:mentions | umls-concept:C0011071 | lld:lifeskim |
| pubmed-article:2773792 | lifeskim:mentions | umls-concept:C0022885 | lld:lifeskim |
| pubmed-article:2773792 | lifeskim:mentions | umls-concept:C0392366 | lld:lifeskim |
| pubmed-article:2773792 | lifeskim:mentions | umls-concept:C0205464 | lld:lifeskim |
| pubmed-article:2773792 | pubmed:issue | 8 | lld:pubmed |
| pubmed-article:2773792 | pubmed:dateCreated | 1989-10-5 | lld:pubmed |
| pubmed-article:2773792 | pubmed:abstractText | Noninvasive stress and pharmacologic tests with procainamide and propafenone were studied as methods to identify patients with Wolff-Parkinson-White syndrome (WPW) who would otherwise be judged at risk of sudden death on the basis of electrophysiologic criteria: the shortest RR interval during induced atrial fibrillation less than or equal to 250 ms or accessory pathway anterograde effective refractory period less than or equal to 250 ms. Sixty-five patients were studied. Twenty-four patients fulfilled the electrophysiologic risk criteria (group A) and 41 patients fulfilled none of these criteria (group B). Persistence of preexcitation during stress test showed a sensitivity of 96% and a specificity of 17% to identify group A patients; its positive predictive value was 40% and negative predictive value 88%. With both procainamide and propafenone tests persistence of preexcitation identified group A patients with a sensitivity of 96% and a specificity of 51%; their positive and negative predictive value were, respectively, 53 and 95%. Stress and pharmacologic tests have good sensitivity and negative predictive value, but low specificity and positive predictive value. | lld:pubmed |
| pubmed-article:2773792 | pubmed:language | eng | lld:pubmed |
| pubmed-article:2773792 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2773792 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:2773792 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2773792 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2773792 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:2773792 | pubmed:month | Sep | lld:pubmed |
| pubmed-article:2773792 | pubmed:issn | 0002-9149 | lld:pubmed |
| pubmed-article:2773792 | pubmed:author | pubmed-author:RiccardiRR | lld:pubmed |
| pubmed-article:2773792 | pubmed:author | pubmed-author:MangiardiLL | lld:pubmed |
| pubmed-article:2773792 | pubmed:author | pubmed-author:BruscaAA | lld:pubmed |
| pubmed-article:2773792 | pubmed:author | pubmed-author:GaitaFF | lld:pubmed |
| pubmed-article:2773792 | pubmed:author | pubmed-author:GiustettoCC | lld:pubmed |
| pubmed-article:2773792 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:2773792 | pubmed:day | 1 | lld:pubmed |
| pubmed-article:2773792 | pubmed:volume | 64 | lld:pubmed |
| pubmed-article:2773792 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:2773792 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:2773792 | pubmed:pagination | 487-90 | lld:pubmed |
| pubmed-article:2773792 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:2773792 | pubmed:meshHeading | pubmed-meshheading:2773792-... | lld:pubmed |
| pubmed-article:2773792 | pubmed:meshHeading | pubmed-meshheading:2773792-... | lld:pubmed |
| pubmed-article:2773792 | pubmed:meshHeading | pubmed-meshheading:2773792-... | lld:pubmed |
| pubmed-article:2773792 | pubmed:meshHeading | pubmed-meshheading:2773792-... | lld:pubmed |
| pubmed-article:2773792 | pubmed:meshHeading | pubmed-meshheading:2773792-... | lld:pubmed |
| pubmed-article:2773792 | pubmed:meshHeading | pubmed-meshheading:2773792-... | lld:pubmed |
| pubmed-article:2773792 | pubmed:meshHeading | pubmed-meshheading:2773792-... | lld:pubmed |
| pubmed-article:2773792 | pubmed:meshHeading | pubmed-meshheading:2773792-... | lld:pubmed |
| pubmed-article:2773792 | pubmed:meshHeading | pubmed-meshheading:2773792-... | lld:pubmed |
| pubmed-article:2773792 | pubmed:meshHeading | pubmed-meshheading:2773792-... | lld:pubmed |
| pubmed-article:2773792 | pubmed:meshHeading | pubmed-meshheading:2773792-... | lld:pubmed |
| pubmed-article:2773792 | pubmed:meshHeading | pubmed-meshheading:2773792-... | lld:pubmed |
| pubmed-article:2773792 | pubmed:meshHeading | pubmed-meshheading:2773792-... | lld:pubmed |
| pubmed-article:2773792 | pubmed:year | 1989 | lld:pubmed |
| pubmed-article:2773792 | pubmed:articleTitle | Stress and pharmacologic tests as methods to identify patients with Wolff-Parkinson-White syndrome at risk of sudden death. | lld:pubmed |
| pubmed-article:2773792 | pubmed:affiliation | Istituto di Medicina e Chirurgia Cardiovascolare, Università di Torino, Italy. | lld:pubmed |
| pubmed-article:2773792 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:2773792 | pubmed:publicationType | Comparative Study | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2773792 | lld:pubmed |
